Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.
about
Marketed drugs used for the management of hypercholesterolemia as anticancer armament.AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response
P2860
Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ranitidine modifies myeloid ce ...... evelopment and spread in mice.
@en
Ranitidine modifies myeloid ce ...... evelopment and spread in mice.
@nl
type
label
Ranitidine modifies myeloid ce ...... evelopment and spread in mice.
@en
Ranitidine modifies myeloid ce ...... evelopment and spread in mice.
@nl
prefLabel
Ranitidine modifies myeloid ce ...... evelopment and spread in mice.
@en
Ranitidine modifies myeloid ce ...... evelopment and spread in mice.
@nl
P2093
P2860
P1433
P1476
Ranitidine modifies myeloid ce ...... development and spread in mice
@en
P2093
Ava Vila-Leahey
Ian D Haidl
Paola A Marignani
Sharon A Oldford
P2860
P304
P356
10.1080/2162402X.2016.1151591
P577
2016-03-10T00:00:00Z